Interpreters as Advocates for Hypertensive Patients

January 20, 2022 updated by: Daryl Thornton, Case Western Reserve University

Interpreters as Advocates for Hispanic Patients With Hypertension

The purpose of the study is to determine if medical interpreters trained to advocate on behalf of their patients deliver improved care compared to standard medical interpreters

Study Overview

Status

Terminated

Conditions

Detailed Description

Over 21 million Americans have limited English proficiency. About two-thirds of these individuals speak Spanish. Limited English proficiency has major adverse impacts on health and health care. Using trained medical interpreters may help overcome this language barrier. Compared to patients who need but don't get an interpreter, patients who use trained medical interpreters have better satisfaction, quality of care, and health outcomes. However, the outcomes of patients using interpreters is often poorer than that of English-speaking patients. This randomized controlled trial will test the utility of using interpreters as advocates for Spanish-speaking inner city patients with hypertension.

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Spanish speaking
  • Limited English proficiency
  • Uncontrolled hypertension
  • Regular visit with primary care provider who is not proficient in Spanish

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Interpreter
Professional Spanish interpreter
A professional medical interpreter accompanies patient to each appointment.
No Intervention: Usual Care
Usual care provided to patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient reported satisfaction with the clinical encounter with their clinician
Time Frame: 6 months
Patients will rate their satisfaction with the clinical encounter with their clinician y responding to several questions about the encounter using a 5-point Likert scale.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Provider reported satisfaction with the clinical encounter with the patient
Time Frame: 6 months
Providers will rate their satisfaction with the clinical encounter with the patient by responding to several questions about the encounter using a 5-point Likert scale.
6 months
Change in systolic and diastolic blood pressure
Time Frame: 6 months
Net change in systolic and diastolic blood pressure
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2010

Primary Completion (Actual)

December 1, 2012

Study Completion (Actual)

January 1, 2014

Study Registration Dates

First Submitted

December 31, 2021

First Submitted That Met QC Criteria

January 20, 2022

First Posted (Actual)

February 1, 2022

Study Record Updates

Last Update Posted (Actual)

February 1, 2022

Last Update Submitted That Met QC Criteria

January 20, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P60MD002265DT2
  • 5P60MD002265-03 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Professional Medical Interpreter

Subscribe